Sponsor: 
GlaxoSmithKline Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Monovalent vaccines

Registered for use in infants and children aged 2 months to 5 years.

Monovalent Haemophilus influenzae type b (Hib) vaccine.

Lyophilised pellet in a monodose vial with separate diluent.

Each 0.5 mL reconstituted dose contains:

  • 10 µg Hib capsular polysaccharide (polyribosyl-ribitol-phosphate) conjugated to approximately 25 µg tetanus toxoid (PRP-T)

For full details, refer to the product information and consumer medicine information sheets for Hiberixv vaccine available on the TGA website.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018

Definitions

PRP
polyribosylribitol phosphate